These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 9202672

  • 1. Protein kinase C inhibits epidermal growth factor receptor phosphorylation in enterocytes.
    Summers ST, Bass BL.
    J Surg Res; 1997 Apr; 69(1):208-11. PubMed ID: 9202672
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F, Hui YN, Li YJ, Guo CM, Meng H.
    Ophthalmologica; 2007 Apr; 221(4):244-50. PubMed ID: 17579290
    [Abstract] [Full Text] [Related]

  • 3. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH, Olivares-Reyes JA, Catt KJ.
    Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
    [Abstract] [Full Text] [Related]

  • 4. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Jan; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
    Zolfaghari A, Djakiew D.
    Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
    [Abstract] [Full Text] [Related]

  • 6. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 7. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W, Kiguchi K, Imamoto A, Rupp T, Zilberstein A, DiGiovanni J.
    Cell Growth Differ; 1995 Nov 07; 6(11):1447-55. PubMed ID: 8562483
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
    Mermelstein FH, Abidi TF, Laskin JD.
    Mol Pharmacol; 1989 Dec 07; 36(6):848-55. PubMed ID: 2557535
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.
    J Cell Physiol; 1997 Jul 07; 172(1):69-78. PubMed ID: 9207927
    [Abstract] [Full Text] [Related]

  • 10. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J, Ma C, Huang Y, Luo J, Huang C.
    Oncogene; 2003 Jan 16; 22(2):211-9. PubMed ID: 12527890
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ, Houtman JC, Cha D, Bertics PJ.
    J Cell Physiol; 1997 Oct 16; 173(1):44-53. PubMed ID: 9326448
    [Abstract] [Full Text] [Related]

  • 12. Modulation of EGF-receptors by phorbol ester in small intestinal crypt cells.
    Baliga BS, Borowitz SM, Barnard JA.
    Biochem Int; 1990 Oct 16; 20(1):161-8. PubMed ID: 2328019
    [Abstract] [Full Text] [Related]

  • 13. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2000 Jun 16; 183(3):338-46. PubMed ID: 10797308
    [Abstract] [Full Text] [Related]

  • 14. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 16; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A.
    Connor P, Talavera F, Kang JS, Burke J, Roberts J, Menon KM.
    Gynecol Oncol; 1997 Oct 16; 67(1):46-50. PubMed ID: 9345355
    [Abstract] [Full Text] [Related]

  • 16. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
    Gallardo G, Tabraue C, Quintana J, López-Blanco F, Cabrera J, Díaz R, Estévez F, Ruiz de Galarreta CM, Fanjul LF, Santana P.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 16; 46(7):1305-12. PubMed ID: 11075960
    [Abstract] [Full Text] [Related]

  • 17. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K, Idezawa T, You XJ, Kothari NH, Fan H, Korc M.
    Cancer Res; 2002 Oct 01; 62(19):5611-7. PubMed ID: 12359775
    [Abstract] [Full Text] [Related]

  • 18. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.
    Cancer Res; 2004 Jul 15; 64(14):4931-41. PubMed ID: 15256466
    [Abstract] [Full Text] [Related]

  • 19. Phorbol ester reduces phosphorylation of epidermal growth factor receptor in pancreatic cancer cells by activation of a tyrosine phosphatase.
    Ho JJ, Farrelly ER, Kim YS.
    Biochem Biophys Res Commun; 1999 Nov 30; 265(3):728-33. PubMed ID: 10600488
    [Abstract] [Full Text] [Related]

  • 20. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
    Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM.
    Exp Cell Res; 2008 Oct 01; 314(16):2907-18. PubMed ID: 18687326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.